Up a level |
(2018) Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artificial cells, nanomedicine, and biotechnology. pp. 1-17. ISSN 2169-141X